Innovation in antiviral therapeutics

Effecta Pharma

Mosquito 3DEffecta Pharma Limited is a UK-based company dedicated to the discovery and development of innovative medicines to treat viral diseases, focussing on small molecule antivirals for flaviruses like Dengue, Chikungunya and Zika as well other human viral disease including rhinovirus infections.

Effecta is an early stage company  founded by a team with a significant track-record in drug discovery and development and building biotech companies.

We are interested in early stage partnerships with biotech and pharma companies, charity organisations and academic researchers. Investors interested in impact investments including high net worth individuals are welcome to contact to us.